Dysarthria
29
10
13
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (29)
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Chinese-Specific Speech Imagery Coding Using High-Density ECoG
ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
The Role of Cerebellum in Speech
Dysarthria Management for Minor Groups
Development of Dual Language (Urdu and English) Digital Software for SA, Management Of Adult Dysarthria
INcorporating VoIce AcTivated Communication Aids Into Everyday Communication
Application of Ideal Binary Masking to Disordered Speech
Speech and Arm Combined Exergame
Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech
Perceptual Training to Improve Listeners' Ability to Understand Speech Produced by Individuals With Dysarthria
Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke
Subthalamic Nucleus Deep Brain Stimulation in Speech Study
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy
Non-invasive Brain Stimulation as a Treatment for Dysarthria Post-stroke
Speech Motor Treatment in Cerebral Palsy
Laryngeal Adaptation for Speech and Swallowing